Research Reports

Key takeaways

EGM on May 8, 2026 approved share consolidation ranging from every 3 to every 400 shares into 1 share.

Board to determine exact ratio within range by Effective Date, not later than June 30, 2026.

Specific consolidation of every 8 shares of US$0.0003125 par value into 1 share of US$0.0025 par value effective May 19, 2026.

Class A ordinary shares continue trading as NCI on Nasdaq Capital Market with new CUSIP G6421C138.

Applies to both issued and unissued Class A and Class B ordinary shares of par value US$0.0003125 each.

Full analysis

The approval of the share consolidation at the Extraordinary General Meeting on May 8, 2026, provides the board flexibility to select a ratio between every 3 to 400 existing shares into one new share, with the specific implementation set at an 8:1 ratio reflected on Nasdaq starting May 19, 2026. This adjusts the par value from US$0.0003125 to US$0.0025 per share for both Class A and Class B ordinary shares, covering both issued and unissued shares. The continuity of trading under the NCI symbol with a new CUSIP G6421C138 ensures minimal disruption for investors. Such consolidations typically aim to meet exchange listing requirements or improve share price attractiveness, though the filing does not specify the rationale.

NCI · Neo-Concept International Group Holdings Limited

Summary

Key takeaways

Full analysis